Taipei-based Oneness Biotech Co. Ltd. (合一生技) set the price for its global depositary receipt (GDR) issuance on Wednesday that will make it the biggest ever overseas fundraising case by a company in Taiwan's biomedical sector.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
-
Politics
Ex-police, firefighters lodge suit against gov't amid pension dispute
02/05/2026 06:43 PM -
Business
Taiwan's consumer price index eases to 0.69% in January
02/05/2026 06:40 PM -
Cross-Strait
Hong Kong activist's Taipei boxing studio vandalized again with red paint
02/05/2026 06:13 PM -
Business
Hon Hai posts record January revenue, expects stronger-than-usual Q1
02/05/2026 06:06 PM -
Society
Taichung restaurant temporarily closed over suspected food poisoning
02/05/2026 05:58 PM